Methicillin-resistant Staphylococcus aureus bacteremia during the coronavirus disease 2019 (COVID-19) pandemic: Trends and distinguishing characteristics among patients in a healthcare system in New York City

Infect Control Hosp Epidemiol. 2023 Jul;44(7):1177-1179. doi: 10.1017/ice.2022.238. Epub 2022 Sep 9.

Abstract

During the pandemic, the rate of healthcare facility-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia was 5 times greater in patients admitted with coronavirus disease 2019 (COVID-19). The presence of central lines and mechanical ventilation likely contribute to this increased rate. The number of central-line-associated bacteremia cases may be underestimated in patients with COVID-19.

MeSH terms

  • Bacteremia* / diagnosis
  • Bacteremia* / epidemiology
  • COVID-19*
  • Cross Infection* / epidemiology
  • Delivery of Health Care
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • New York City / epidemiology
  • Pandemics
  • Staphylococcal Infections* / diagnosis
  • Staphylococcal Infections* / epidemiology